44.221.70.232
dgid:
enl:
npi:0
-Advertisement-

Geographic Atrophy

GALE study assesses long-term efficacy, safety of pegcetacoplan for geographic atrophy

The GALE study demonstrated long-term safety and efficacy trends for patients with geographic atrophy (GA) who were treated with intravitreal pegcetacoplan. The study was presented at the 2024 ARVO Annual Meeting in Seattle, Washington. The open-label extension study allowed patients participating in the phase 3 OAKS and DERBY studies to...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-